Abstract
Thyroid Cancer (TC) due to several genetic changes confer a proliferative advantage to the follicular cell. Platforms based on these changes have been improving the diagnosis, however, do not focus on prognosis analysis and routine assessment of the possibility of cancer recurrence and metastasis. The expression of microRNAs (miRNAs) on the routine evaluations can help this issue, given t…